KLOW BPC-157 10mg+GHK-CU 50mg+TB-500 10mg+KPV 20mg

What is KLOW BPC-157 10mg+GHK-CU 50mg+TB-500 10mg+KPV 20mg

“Klow” is a multi-component research peptide blend designed for controlled laboratory use. It combines the following research peptides into a single vial for experimental research: BPC-157, GHK-Cu, TB500 (a fragment related to thymosin beta-4), and KPV.

In peptide research classifications, “Klow” is a healing and regenerative peptide blend. Each individual component has been studied in preclinical models:

• BPC-157 (molecular weight: 1419.556 g/mol) is a synthetic fragment derived from a gastric protein, frequently examined in rodent studies on gastrointestinal integrity, vascular changes, and soft-tissue injury.
• GHK-Cu (molecular weight: 401.91 g/mol) is a naturally occurring copper-binding tripeptide studied for its role in skin biology, extracellular matrix remodeling, and wound repair models.
• TB500 (molecular weight: 4963.44 g/mol) is a short peptide fragment derived from thymosin beta-4, a protein involved in cell migration and angiogenesis (new blood vessel formation) in experimental systems.
• KPV (molecular weight: 384.48 g/mol) is derived from the C-terminal end of α-MSH and has been investigated in models of intestinal and airway inflammation, as well as epithelial barrier function.

“Klow” is intended for in-vitro and non-clinical in-vivo research only. It is not approved for human or veterinary use, and no therapeutic or performance claims are made for this formulation.